The neutrophil-lymphocyte ratio, alkaline phosphatase, and CRP proved to be highly significant parameters.
← all excerpts
Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Patients Treated with Regorafenib as Part of the CORRECT and CONSIGN Trials.
1
—
—